Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Kirkpatrick

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Die Pharmazie|September 1, 1988
Evaluation of some azines of aminomethylacetophenones and related quaternary ammonium compounds versus the EMT6 tumourJ R Dimmock, E Erciyas, D L Kirkpatrick, et al.
Oncology Research|January 1, 1997
Redox active disulfides: the thioredoxin system as a drug targetD L Kirkpatrick, G Ehrmantraut, S Stettner, et al.
Journal of Pharmaceutical Sciences|January 1, 1982
Effect of 4-dimethylaminomethyl-1-(3-hydroxyphenyl)-1-nonen-3-one hydrochloride and related compounds on respiration in rat liver mitochondriaN W Hamon, D L Kirkpatrick, E W Chow, et al.
Journal of Pharmaceutical Sciences|September 1, 1982
Synthesis and evaluation of some alkoxy-, chloro-, and acyloxy-conjugated styryl ketones against P-388 lymphocytic leukemia and an examination of the metabolism and toxicological effects of 1-(m-ethoxymethyloxyphenyl)-1-nonen-3-one in ratsJ R Dimmock, D L Kirkpatrick, N G Webb, et al.
Anti-Cancer Drug Design|April 15, 2000
Parallel syntheses of disulfide inhibitors of the thioredoxin redox system as potential antitumor agentsD L Kirkpatrick, S Watson, M Kunkel, et al.
Drug Design and Delivery|December 1, 1990
Cytotoxicity of Mannich bases of alpha-arylidene-beta-ketoesters and related compounds against EMT6 mammary carcinoma cellsJ R Dimmock, E Erciyas, G E Bigam, et al.
The American Journal of Physiology|January 14, 1999
Effect of angiotensin-converting enzyme inhibition on protein kinase C and SR proteins in heart failureY Takeishi, A Bhagwat, N A Ball, et al.
Circulation Research|June 24, 2000
Transgenic overexpression of constitutively active protein kinase C epsilon causes concentric cardiac hypertrophyY Takeishi, P Ping, R Bolli, et al.
Oncology Research|January 1, 1994
The thioredoxin/thioredoxin reductase redox system and control of cell growthG Powis, J E Oblong, P Y Gasdaska, et al.
Biochemical Pharmacology|December 13, 1996
Oxidative inactivation of thioredoxin as a cellular growth factor and protection by a Cys73-->Ser mutationJ R Gasdaska, D L Kirkpatrick, W Montfort, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Die Pharmazie|September 1, 1988
Evaluation of some azines of aminomethylacetophenones and related quaternary ammonium compounds versus the EMT6 tumourJ R Dimmock, E Erciyas, D L Kirkpatrick, et al.
Oncology Research|January 1, 1997
Redox active disulfides: the thioredoxin system as a drug targetD L Kirkpatrick, G Ehrmantraut, S Stettner, et al.
Journal of Pharmaceutical Sciences|January 1, 1982
Effect of 4-dimethylaminomethyl-1-(3-hydroxyphenyl)-1-nonen-3-one hydrochloride and related compounds on respiration in rat liver mitochondriaN W Hamon, D L Kirkpatrick, E W Chow, et al.
Journal of Pharmaceutical Sciences|September 1, 1982
Synthesis and evaluation of some alkoxy-, chloro-, and acyloxy-conjugated styryl ketones against P-388 lymphocytic leukemia and an examination of the metabolism and toxicological effects of 1-(m-ethoxymethyloxyphenyl)-1-nonen-3-one in ratsJ R Dimmock, D L Kirkpatrick, N G Webb, et al.
Anti-Cancer Drug Design|April 15, 2000
Parallel syntheses of disulfide inhibitors of the thioredoxin redox system as potential antitumor agentsD L Kirkpatrick, S Watson, M Kunkel, et al.
Drug Design and Delivery|December 1, 1990
Cytotoxicity of Mannich bases of alpha-arylidene-beta-ketoesters and related compounds against EMT6 mammary carcinoma cellsJ R Dimmock, E Erciyas, G E Bigam, et al.
The American Journal of Physiology|January 14, 1999
Effect of angiotensin-converting enzyme inhibition on protein kinase C and SR proteins in heart failureY Takeishi, A Bhagwat, N A Ball, et al.
Circulation Research|June 24, 2000
Transgenic overexpression of constitutively active protein kinase C epsilon causes concentric cardiac hypertrophyY Takeishi, P Ping, R Bolli, et al.
Oncology Research|January 1, 1994
The thioredoxin/thioredoxin reductase redox system and control of cell growthG Powis, J E Oblong, P Y Gasdaska, et al.
Biochemical Pharmacology|December 13, 1996
Oxidative inactivation of thioredoxin as a cellular growth factor and protection by a Cys73-->Ser mutationJ R Gasdaska, D L Kirkpatrick, W Montfort, et al.
Pageof 5